213 related articles for article (PubMed ID: 32276795)
1. Tattooing among Iranian prisoners: results of the two national biobehavioral surveillance surveys in 2015-2016.
Jafari S; Moradi G; Zareie B; Gouya MM; Zavareh FA; Ghaderi E
An Bras Dermatol; 2020; 95(3):289-297. PubMed ID: 32276795
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Drug Injection in High-Risk Populations of Prisoners with a History of Tattooing: A Cross-Sectional Study.
Jafari S; Moradi G; Gouya MM; Azimian Zavareh F; Ghaderi E
J Res Health Sci; 2019 Jan; 19(1):e00435. PubMed ID: 31133625
[TBL] [Abstract][Full Text] [Related]
3. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
Navadeh S; Mirzazadeh A; Gouya MM; Farnia M; Alasvand R; Haghdoost AA
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii33-6. PubMed ID: 23986417
[TBL] [Abstract][Full Text] [Related]
4. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
[TBL] [Abstract][Full Text] [Related]
6. Patterns of sexual behaviors and related factors among prisoners in Iran: results from a national survey in 2015.
Moradi G; Mohamadi-Bolbanabad A; Darvishi S; Azimian Zavareh F; Piroozi B; Zareie B; Gouya MM; Tashakorian M
Int J Prison Health; 2019 Sep; 16(1):29-37. PubMed ID: 32040273
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
8. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
9. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Poulin C; Courtemanche Y; Serhir B; Alary M
Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing Among Prison Inmates.
Moazen B; Saeedi Moghaddam S; Silbernagl MA; Lotfizadeh M; Bosworth RJ; Alammehrjerdi Z; Kinner SA; Wirtz AL; Bärnighausen TW; Stöver HJ; Dolan KA
Epidemiol Rev; 2018 Jun; 40(1):58-69. PubMed ID: 29860343
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Drug Use and Related Factors Among Prisoners in Iran: Results from the National Survey in 2015.
Moradi G; Darvishi S; Asaadi L; Azimian Zavareh F; Gouya MM; Tashakorian M; Alasvand R; Mohamadi Bolbanabad A
J Prim Prev; 2020 Feb; 41(1):29-38. PubMed ID: 31912408
[TBL] [Abstract][Full Text] [Related]
12. Body art practices among inmates: Implications for transmission of bloodborne infections.
Abiona TC; Balogun JA; Adefuye AS; Sloan PE
Am J Infect Control; 2010 Mar; 38(2):121-9. PubMed ID: 19822379
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015.
Moradi G; Gouya MM; Azimizan Zavareh F; Mohamadi Bolbanabad A; Darvishi S; Aghasadeghi MR; Nabavi M; Alasvand R; Tashakorian M; Nouri B; Rahmani K; Molaei L
Trop Med Int Health; 2018 Jun; 23(6):641-649. PubMed ID: 29698576
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
[TBL] [Abstract][Full Text] [Related]
15. HIV in prison: what are the risks and what can be done?
Hellard ME; Aitken CK
Sex Health; 2004; 1(2):107-13. PubMed ID: 16334992
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.
Peña-Orellana M; Hernández-Viver A; Caraballo-Correa G; Albizu-García CE
J Health Care Poor Underserved; 2011 Aug; 22(3):962-82. PubMed ID: 21841290
[TBL] [Abstract][Full Text] [Related]
17. Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
Hodžić H; Bajramović A; Obradović Z; Mahmić-Kaknjo M
Med Glas (Zenica); 2017 Feb; 14(1):73-78. PubMed ID: 28165441
[TBL] [Abstract][Full Text] [Related]
18. Tattoos and body piercings in the United States: a national data set.
Laumann AE; Derick AJ
J Am Acad Dermatol; 2006 Sep; 55(3):413-21. PubMed ID: 16908345
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and Related Risk Behaviors of Hepatitis C, Hepatitis B and HIV Infections among Male Prisoners in Kermanshah, Iran.
Khademi N; Skakiba E; Khodadoust M; Khoramdad M
Arch Iran Med; 2019 Oct; 22(10):588-591. PubMed ID: 31679361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
